4-demethoxydaunorubicin
Term · Oncology and biomedicine · MLC-T-ONC-000057
A drug used with other drugs to treat adults with acute myeloid leukemia. It is also being studied in the treatment of other types of cancer. 4-demethoxydaunorubicin blocks a certain enzyme needed for cell division and DNA repair and may kill cancer cells. It is a type of anthracycline antibiotic and a type of topoisomerase inhibitor. Also called Idamycin PFS and idarubicin hydrochloride.
| Identifier | MLC-T-ONC-000057 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Idamycin PFS; idarubicin hydrochloride |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000057",
"term": "4-demethoxydaunorubicin",
"field": "Oncology and biomedicine",
"definition": "A drug used with other drugs to treat adults with acute myeloid leukemia. It is also being studied in the treatment of other types of cancer. 4-demethoxydaunorubicin blocks a certain enzyme needed for cell division and DNA repair and may kill cancer cells. It is a type of anthracycline antibiotic and a type of topoisomerase inhibitor. Also called Idamycin PFS and idarubicin hydrochloride.",
"synonyms": [
"Idamycin PFS",
"idarubicin hydrochloride"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/4-demethoxydaunorubicin/"
}
Record 87 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.